HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 3,200 shares, an increase of 60.0% from the March 31st total of 2,000 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio […]
HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 3,400 shares, an increase of 17.2% from the November 15th total of 2,900 shares. Based on an average daily volume of 1,800 shares, the days-to-cover ratio […]
HLS Therapeutics (OTCMKTS:HLTRF – Free Report) had its target price trimmed by Stifel Nicolaus from C$15.00 to C$12.25 in a research report sent to investors on Tuesday morning, FlyOnTheWall reports. Separately, Raymond James reduced their target price on HLS Therapeutics from C$10.00 to C$9.00 in a report on Friday, July 28th. Check Out Our Latest […]
HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 600 shares, a drop of 14.3% from the August 15th total of 700 shares. Based on an average daily volume of 8,600 shares, the days-to-cover ratio […]
HLS Therapeutics Inc. (OTCMKTS:HLTRF – Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 3,700 shares, a growth of 48.0% from the May 31st total of 2,500 shares. Based on an average daily trading volume, of 18,900 shares, […]